|
101
|
332
|
6prcC |
Photosynthetic reaction center from rhodopseudomonas viridis (dg-420314 (triazine) complex) |
|
43
|
129
|
6lyzA |
Real-space refinement of the structure of hen egg-white lysozyme |
|
45
|
129
|
6lytA |
Comparison of radiation-induced decay and structure refinement from x-ray data collected from lysozyme crystals at low and ambient temperatures |
|
58
|
162
|
6lzmA |
Comparison of the crystal structure of bacteriophage t4 lysozyme at low, medium, and high ionic strengths |
|
3
|
50
|
6insE |
X-ray analysis of the single chain b29-a1 peptide-linked insulin molecule. a completely inactive analogue |
|
56
|
146
|
6hbwB |
Crystal structure of deoxy-human hemoglobin beta6 glu->trp |
|
62
|
141
|
6hbwA |
Crystal structure of deoxy-human hemoglobin beta6 glu->trp |
|
66
|
145
|
6hbiA |
Scapharca dimeric hemoglobin, mutant t72v, deoxy form |
|
159
|
437
|
6cscA |
Chicken citrate synthase complex with trifluoroacetonyl-coa and citrate |
|
148
|
433
|
6ctsA |
Proposed mechanism for the condensation reaction of citrate synthase. 1.9-angstroms structure of the ternary complex with oxaloacetate and carboxymethyl coenzyme a |
|
141
|
405
|
6cp4A |
P450cam d251n mutant |
|
174
|
552
|
6coxA |
Cyclooxygenase-2 (prostaglandin synthase-2) complexed with a selective inhibitor, sc-558 in i222 space group |
|
143
|
405
|
6cppA |
Crystal structures of cytochrome p450-cam complexed with camphane, thiocamphor, and adamantane: factors controlling p450 substrate hydroxylation |
|
111
|
291
|
6ccpA |
Effect of arginine-48 replacement on the reaction between cytochrome c peroxidase and hydrogen peroxide |
|
116
|
306
|
6atjA |
Recombinant horseradish peroxidase c complex with ferulic acid |
|
99
|
288
|
5dn6G |
Atp synthase from paracoccus denitrificans |
|
90
|
324
|
5c8nA |
Egfr kinase domain mutant "tmlr" with compound 23 |
|
87
|
324
|
5canA |
Egfr kinase domain mutant "tmlr" with compound 27 |
|
93
|
275
|
5cxzA |
Syk catalytic domain complexed with naphthyridine inhibitor |
|
61
|
152
|
5cn6A |
Ultrafast dynamics in myoglobin: 0.1 ps time delay |
|
39
|
135
|
5fd6A |
Zinc-bound manganese uptake regulator |
|
82
|
193
|
5f0hA |
Structure of transcriptional regulatory repressor protein - ethr from mycobacterium tuberculosis in complex with compound 28 at 1.99a resolution |
|
86
|
282
|
5cepA |
Dlk in complex with inhibitor n-(1-isopropyl-5-(piperidin-4-yl)-1h-pyrazol-3-yl)-4-(trifluoromethyl)pyridin-2-amine |
|
48
|
129
|
5f14A |
Structure of native hen egg-white lysozyme |
|
28
|
102
|
5cbgA |
Calcium activated non-selective cation channel |
|
134
|
411
|
5cfyA |
Crystal structure of gltph r397a in complex with na+ and l-asp |
|
143
|
343
|
5cg5A |
Neutron crystal structure of human farnesyl pyrophosphate synthase in complex with risedronate |
|
179
|
460
|
5f92A |
Fumarate hydratase of mycobacterium tuberculosis in complex with formate |
|
73
|
228
|
5c8dA |
Crystal structure of full-length thermus thermophilus carh bound to adenosylcobalamin (dark state) |
|
90
|
272
|
4pd2A |
Crystal structure of a complex between a c248gh llfpg mutant and a thf containing dna |
|
110
|
291
|
5ccpA |
Histidine 52 is a critical residue for rapid formation of cytochrome c peroxidase compound i |
|
89
|
322
|
5calA |
Egfr kinase domain mutant "tmlr" with compound 24 |
|
152
|
427
|
5c8yB |
Crystal structure of t2r-ttl-plinabulin complex |
|
88
|
271
|
4pdgA |
Crystal structure of a complex between an inhibited llfpg and a thf containing dna |
|
55
|
134
|
5do9B |
Structure of regulator of g protein signaling 8 (rgs8) in complex with alf4-activated galpha-q |
|
92
|
324
|
5casA |
Egfr kinase domain mutant "tmlr" with compound 41a |
|
138
|
343
|
5cg6A |
Neutron crystal structure of human farnesyl pyrophosphate synthase in complex with risedronate and isopentenyl pyrophosphate |
|
94
|
290
|
5cf6A |
Crystal structure of janus kinase 2 in complex with n,n-dicyclopropyl-10-[(2s)-2,3-dihydroxypropyl]-3-methyl-7-(methylamino)-3,5,8,10-tetraazatricyclo [7.3.0.02,6]dodeca-1(9),2(6),4,7,11-pentaene-11-carboxamide |
|
85
|
282
|
5ceoA |
Dlk in complex with inhibitor 2-((6-(3,3-difluoropyrrolidin-1-yl)-4-(1-(oxetan-3-yl)piperidin-4-yl)pyridin-2-yl)amino)isonicotinonitrile |
|
90
|
271
|
4pdiA |
Crystal structure of a complex between an inhibited llfpg and a n7-benzyl-fapy-dg containing dna |
|
157
|
437
|
5cb4A |
Crystal structure of t2r-ttl-tivantinib complex |
|
163
|
427
|
5ca1B |
Crystal structure of t2r-ttl-nocodazole complex |
|
30
|
106
|
5c7aA |
Fragment-based drug discovery targeting inhibitor of apoptosis proteins: compound 7 |
|
97
|
292
|
5cf8A |
Crystal structure of janus kinase 2 in complex with n,n-dicyclopropyl-10-ethyl-7-[(3-methoxypropyl)amino] -3-methyl-3,5,8,10-tetraazatricyclo[7.3.0.0,6] dodeca-1(9),2(6),4,7,11-pentaene-11-carboxamide |
|
28
|
132
|
5a2qR |
Structure of the hcv ires bound to the human ribosome |
|
94
|
322
|
5caqA |
Egfr kinase domain mutant "tmlr" with compound 33 |
|
108
|
327
|
5cspA |
Crystal structure of ck2alpha with compound 5 bound |
|
163
|
437
|
5ca1A |
Crystal structure of t2r-ttl-nocodazole complex |
|
154
|
426
|
5ca0B |
Crystal structure of t2r-ttl-lexibulin complex |
|
98
|
292
|
5cf5A |
Crystal structure of janus kinase 2 in complex with n,n-dicyclopropyl-7-[(dimethyl-1,3-thiazol-2-yl)amino]-10-ethyl-3-methyl-3,5,8,10-tetraazatricyclo[7.3.0.02,6] dodeca-1(9),2(6),4,7,11-pentaene-11-carboxamide |
